The main objective of the Liver Cancer Program is to maintain Mount Sinai at the forefront of hepatocellular carcinoma clinical and translational research in the US. Read More
Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration
May 22, 2013 - Partnership will accelerate the pace of discovery and innovation in Biomedical Sciences.
Ketamine Shows Significant Benefit in People with Treatment-Resistant Depression
May 20, 2013 - Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic.
Assistant, Liver Cancer Research Program
1425 Madison Avenue
New York, NY 10029